Indefinite Delivery Contract 36C24224D0023
- Not listed
- This federal contract IDV award is a Blanket Purchase Agreement (BPA) between the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 2 and Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The single-award BPA, valued at up to $1,415,000, provides chemo compounding services to support the VA's oncology and infusion treatment programs when the agency's on-site compounding capabilities are temporarily unavailable. The contract tasks Optum...
- This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. The contract, valued at up to $2,750,000.00, is for the provision of hazardous pharmaceutical compounds to support VA oncology and infusion treatment programs in the Las Vegas, Nevada area. Avella Specialty Pharmacy is a 503A...
- This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to provide nationwide chemo compounding services. The contract has a ceiling value of $567,000.00 and a period of performance through September 30, 2025. Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, is a 503A certified pharmacy that specializes in complex pharmaceutical compounding, particularly...
- The U.S. Department of Veterans Affairs (VA) awarded an Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, for contingency hazardous pharmaceutical compounding services. The contract, with a ceiling value of $4,000,000, is to support the VA Sierra Nevada Health Care System in Reno, Nevada, and has a period of performance from May 1, 2024 to September 30, 2028. Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, will...
- This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to provide hazardous chemotherapy compounding services for the VA's Veterans Integrated Service Network (VISN) 10, which covers Ohio, Michigan, and Indiana. The $4,135,790.32 IDC has a period of performance from May 1, 2024 to April 30, 2026. It was a full and open competition without any set-asides. The contract aims to...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 awarded a single award, indefinite delivery contract valued at up to $4,050,000 to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. Two firm fixed price delivery orders have been issued against the contract to date for 503A Pharmaceutical Drug Compounding Services. The first delivery order, issued on August 25, 2023, is...
- Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated and operating as Avella Of Deer Valley, Inc #038, was awarded a single-award Indefinite Delivery Contract by Veterans Integrated Service Network 22 (VISN 22) on October 1, 2024, with a ceiling value of $2,012,758.65 and ultimate completion date of September 30, 2026. The contract covers the supply and delivery of compounded chemotherapy medications and specialized pharmaceutical preparation services to support the U.S....
- Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated and operating as Avella Specialty Pharmacy, was awarded a single-award Indefinite Delivery Contract (IDC) by the Department of Veterans Affairs Veterans Integrated Service Network 17 on June 1, 2020, with a ceiling value of $10,000,000 and an ultimate completion date of October 31, 2025. This civilian contract, awarded through full and open competition with no set-aside designation, procures specialized pharmacy...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded a single-award indefinite delivery contract to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy. The contract has a potential value of $1.5 million and a period of performance through June 1, 2020 for the delivery of intravenous oncolytics compounding on an as-needed basis. Under this arrangement, the agency has issued a firm fixed price delivery order worth...
- The Department of Veterans Affairs, Veterans Integrated Service Network 2 (VISN 2) awarded a single-award Blanket Purchase Agreement with a $500,000 ceiling value to Optum Infusion Services 308, LLC (a subsidiary of UnitedHealth Group Incorporated) on August 24, 2021, with an ultimate completion date of August 23, 2026. The contract procures chemotherapy compound chemical mixes, which are specialized pharmaceutical preparations used to support oncology and cancer treatment services provided to...
- 36C24224D0023Indefinite Delivery Contract
- 1Federal Contract Awards
The federal contract IDV award is for Chemo Compounding Services provided by Optum Pharmacy 801, Inc. (dba Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated. As the prime contractor, Avella will be responsible for compounding customized chemotherapy agents, hazardous sterile preparations, intravenous solutions, and other medications based on patient-specific orders to support the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) healthcare programs for veterans nationwide. The contract is a single-award Indefinite Delivery Contract with a ceiling value of $1,370,000 and a period of performance through September 30, 2024. A $685,000 firm fixed price delivery order was awarded under this IDV on December 11, 2023 for a 6-month period of performance, with Avella providing the compounding services at its facility in Phoenix, Arizona. Avella has multiple other federal contract IDVs with the VA-VHA to provide specialized pharmaceutical compounding, including a $10 million IDC and $2.5 million BPA for nationwide chemotherapy compounding through 2026, as well as a $4 million multi-award BPA for hazardous pharmacy compounding services. These contracts establish Avella as a key supplier of customized medications for the VA's integrated service networks and treatment programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 6/7/24 | |
| Not listed | Not listed | $0 | 12/11/23 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 36C24224D0023-36C24224N0221 | Optum Pharmacy 801, Inc. | $674.8k | 12/11/23 | 9/30/25 | 9/2/25 |